Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8467 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8467 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8467 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8355 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8267 |
Intermediate Similarity |
NPD37 |
Approved |
0.7987 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7949 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7868 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7815 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7785 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7708 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7692 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7692 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7688 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7682 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7682 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7682 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7676 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7658 |
Intermediate Similarity |
NPD919 |
Approved |
0.7651 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7635 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7532 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7516 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7469 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7466 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7464 |
Intermediate Similarity |
NPD17 |
Approved |
0.7463 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7453 |
Intermediate Similarity |
NPD1247 |
Approved |
0.744 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7405 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7405 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7379 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7355 |
Intermediate Similarity |
NPD920 |
Approved |
0.7347 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7305 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7305 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7289 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7279 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7279 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7267 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7254 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7254 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7237 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7234 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7226 |
Intermediate Similarity |
NPD3146 |
Approved |
0.7226 |
Intermediate Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7215 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7212 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7193 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7184 |
Intermediate Similarity |
NPD7296 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7172 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.717 |
Intermediate Similarity |
NPD6386 |
Approved |
0.717 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7161 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7123 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7122 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7118 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7111 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7111 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7097 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7089 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7089 |
Intermediate Similarity |
NPD4210 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7083 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7083 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7078 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.707 |
Intermediate Similarity |
NPD1512 |
Approved |
0.707 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7044 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7039 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7032 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7027 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7021 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7021 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7021 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7021 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7019 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD1933 |
Approved |
0.6993 |
Remote Similarity |
NPD1375 |
Discontinued |
0.6993 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD5711 |
Approved |
0.6988 |
Remote Similarity |
NPD5710 |
Approved |
0.6983 |
Remote Similarity |
NPD4420 |
Approved |
0.698 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.6978 |
Remote Similarity |
NPD7680 |
Approved |
0.6974 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6974 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6972 |
Remote Similarity |
NPD1778 |
Approved |
0.6968 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6948 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6944 |
Remote Similarity |
NPD9269 |
Phase 2 |
0.6943 |
Remote Similarity |
NPD4357 |
Discontinued |
0.694 |
Remote Similarity |
NPD3134 |
Approved |
0.6939 |
Remote Similarity |
NPD9494 |
Approved |
0.6934 |
Remote Similarity |
NPD228 |
Approved |
0.6933 |
Remote Similarity |
NPD1240 |
Approved |
0.6928 |
Remote Similarity |
NPD6100 |
Approved |
0.6928 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6928 |
Remote Similarity |
NPD2531 |
Phase 2 |
0.6928 |
Remote Similarity |
NPD6099 |
Approved |
0.6919 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6918 |
Remote Similarity |
NPD5403 |
Approved |
0.6905 |
Remote Similarity |
NPD2403 |
Approved |
0.6903 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6903 |
Remote Similarity |
NPD2800 |
Approved |
0.6903 |
Remote Similarity |
NPD2654 |
Approved |
0.6901 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6899 |
Remote Similarity |
NPD5401 |
Approved |
0.6899 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD4359 |
Approved |
0.6894 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6892 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6892 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.689 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6887 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD7315 |
Approved |
0.6886 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6879 |
Remote Similarity |
NPD7124 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD3686 |
Approved |
0.6875 |
Remote Similarity |
NPD3687 |
Approved |
0.6875 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6871 |
Remote Similarity |
NPD1019 |
Discontinued |
0.6867 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6863 |
Remote Similarity |
NPD2799 |
Discontinued |
0.686 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.686 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6859 |
Remote Similarity |
NPD3750 |
Approved |
0.6852 |
Remote Similarity |
NPD7411 |
Suspended |
0.6848 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6846 |
Remote Similarity |
NPD7095 |
Approved |
0.6842 |
Remote Similarity |
NPD1607 |
Approved |
0.6842 |
Remote Similarity |
NPD2653 |
Approved |
0.6839 |
Remote Similarity |
NPD5958 |
Discontinued |
0.6835 |
Remote Similarity |
NPD1241 |
Discontinued |
0.6829 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6829 |
Remote Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.6821 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6815 |
Remote Similarity |
NPD2219 |
Phase 1 |
0.6803 |
Remote Similarity |
NPD2797 |
Approved |
0.6803 |
Remote Similarity |
NPD6362 |
Approved |
0.6803 |
Remote Similarity |
NPD3267 |
Approved |
0.6803 |
Remote Similarity |
NPD3266 |
Approved |
0.68 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6797 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6788 |
Remote Similarity |
NPD2067 |
Discontinued |
0.6781 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6781 |
Remote Similarity |
NPD4749 |
Approved |
0.6779 |
Remote Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.6776 |
Remote Similarity |
NPD3657 |
Discovery |
0.6776 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6776 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6774
|
Remote Similarity |
NPD5763 |
Approved |